MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517020502 A) filed by Joanneum Research Forschungsgesellschaft Mbh Health, Graz, Austria, on March 6, for 'optimal bioequivalence.'
Inventor(s) include Sinner Frank; Raml Reingard; Tiffner Katrin; Birngruber Thomas; and Bodenlenz Manfred.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a method for investigating bioequivalence of a topically applied or appliable test substance with respect to a reference substance the method comprising: evaluating whether there is bioequivalence of the test substance with respect to the reference substance based on a) first application site data comprising data indicative for a dermal situation relating to the test substance or the reference substance below a first application site onto which the test substance or the reference substance has been applied and based on b) second application site data comprising data indicative for a dermal situation relating to the test substance or the reference substance below a second application site onto which the test substance or the reference substance has been applied wherein each of the first application site data and the second application site data comprises region data indicative for the dermal situation in a region below the respective application site wherein at least one of the first application site data and the second application site data comprises or both of the first application site data and the second application site data comprise region data for a plurality of distinct regions below the respective application site."
The patent application was internationally filed on Aug. 11, 2022, under International application No.PCT/EP2022/072606.
Disclaimer: Curated by HT Syndication.
